Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPDH Magnussen, Peter M.A. Calverley, Emiel F.�M. Wouters et al.|New England Journal of Medicine|2014Cited by 621
An official European Respiratory Society statement on physical activity in COPDHenrik Watz, Martijn A. Spruit, Fábio Pitta et al.|European Respiratory Journal|2014Cited by 519
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialHenrik Watz, Peter M.A. Calverley, Kay Tetzlaff et al.|The Lancet Respiratory Medicine|2016Cited by 420
Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)Roland Buhl, Eric Bateman, François Maltais et al.|European Respiratory Journal|2015Cited by 322
Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) modelHnin Aung, Kristina Vermeersch, Hamish McAuley et al.|The Lancet Respiratory Medicine|2025Cited by 7